The innovation, he says, could transform the way scientists measure and address genomic breaks in gene-editing systems.

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.

IntelliGenome, an innovative molecular diagnostic solutions provider, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to its ...

Once a cut is made, it is a multistep, imperfect process of cellular DNA repair. CRISPR can be used to make other types of edits too, such as increasing or decreasing the effects of a gene ...

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to cut, replace, or delete mutations in DNA. It can also modify gene ...

Escobar uses CRISPR-Cas9, which is often described as “gene-editing scissors” and for which a Nobel Prize was awarded in 2020. The molecular scissors are guided to a precise location along a DNA ...

Mutations in the BRCA2 gene can prevent DNA repair and thus predispose carriers to malignancies ... informs the clinical management of hereditary cancers. The study used CRISPR-Cas9 technology, a ...

CRISPR is a powerful gene-editing tool that holds enormous potential for treating genetic diseases by allowing scientists to cut, replace, or delete mutations in DNA. It can also modify gene ...

To fix the dysferlin mutation, Escobar uses CRISPR-Cas9, which is often described ... forcing the cell to repair the DNA. The aim is for the mutation to be corrected during the repair process ...

The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage ...